Brought to you by 
Topigen Pharmaceuticals raises $24.1mm in venture round
12 Oct 2005
Executive Summary
Topigen Pharmaceuticals (respiratory disease therapeutics) has raised $19mm ($Cdn22.6mm) with its second round. New investors Desjardins Venture Capital and Business Development Bank of Canada joined returning backers Fonds de Solidarite FTQ, Innovatech Montreal, and the limited partnership Societe en Commandite.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Antisense, Oligonucleotides
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Topigen Pharmaceuticals raises $24.1mm in venture round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice